Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon-alfa 2a in Polycythemia Vera
NCT00241241Phase 2Completed
- Sponsor
- PV-Nord
- Start
- Sep 2004
- Primary completion
- Oct 2006
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa in polycythemia vera (PV), sponsored by PV-Nord. Primary endpoint: Response rate after one year of treatment at 1 year. Started Sep 2004; status: completed.
02
Drugs
interferon alfa
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT00241241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241241.